You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
宜華健康(000150.SZ)擬定增募資不超6.64億元 全部由新里程健康認購
格隆匯 01-12 15:23

格隆匯 1 月 12日丨宜華健康(000150.SZ)披露2021年度非公開發行A股股票預案,擬非公開發行股票的發行對象為北京新里程健康產業集團有限公司(“新里程健康”)新里程健康擬以現金方式一次性認購此次非公開發行的股份。

次非公開發行股票募集資金總額不超過663,539,353元,發行股票數量不超過263,309,267股,未超過此次發行前上市公司總股本的30%,擬全部由里程健康認購。

次非公開發行股票的定價基準日為公司第八屆董事會第會議決議公吿日(2021112日),發行價格2.52/股。

此次發行前新里程健康直接持有宜華健康3510.7902萬股股份,佔宜華健康總股本比例為4.00%。2021111日,根據新里程健康與宜華集團簽署的《表決權委託協議》,宜華集團將其所持宜華健康8776.9756萬股股份(佔宜華健康總股本的10%)的全部表決權、提名和提案權、參會權以及除收益權和股份轉讓權等財產性權利之外的其他權利不可撤銷地委託給新里程健康行使。

同時若按照此次非公開發行股份上限進行匡算,此次發行完成後新里程健康將合計控制宜華健33.85%的表決權,成為公司控股股東,此次非公開發行構成關聯交易。

募集資金總額在扣除發行費用後530,831,482元用於償還銀行貸款,其餘資金用於補充流動資金。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account